Service procedures | Specification | Timeline | Deliverables | Guarantee | Price |
---|---|---|---|---|---|
① Antigen preparationQuote! |
Please refer to antigen production service |
Please fill in the form and send it to [email protected] |
|||
② Antigen validation |
? Analysis of client's antigen by SDS-PAGE and UV | 1-2 days | ? Antibody H and L chains sequences ? Purified mAb ? Vectors containing H and L chain, respectively ? Experimental report |
ELISA positive for immunogen | |
③ Immunization and serum titer test |
? Pre-immune bleed ? 2 rabbits immunization ? Serum titer test ? Final bleed |
8-10 weeks | |||
④ Library construction & screening |
4-6 weeks | ||||
⑤ Antibody production & purification |
? Vector construction ? Transient transfection of HEK293 cells ? Purified by protein A affinity chromatography |
2-3 weeks | |||
⑥ QC analysis |
? Analysis by SDS-PAGE and UV ? ELISA validation |
3 days |
Recombinant protein antigen | Peptide antigen | ||
---|---|---|---|
Antigen quantities | 2.5-4mg/rabbit? | ? KLH/VLP conjugated peptides | 3-5mg/rabbit? |
Antigen Size? | >10kD | ? Concentration? | >0.5mg/mL? |
SDS-Page purity? | >90% | ? OVA/Biotin conjugated peptides? | 2-3mg |
Concentration? | >0.5mg/mL? | ? Concentration? | >0.1mg/mL? |
Formulation? | PBS, if not PBS, please inquire first | ? Formulation | PBS, if not PBS, please inquire first |
江西体彩11选5多乐彩走势图今天 www.phcnlx.com.cn Sino Biological Inc. has established a high-throughput rabbit monoclonal antibody development & production technology platform. Rabbit monoclonal antibodies independently developed by this platform have better affinity and antigen detection limit than traditional mouse monoclonal antibodies.
The rabbit Mab developed by Sino Biological Inc. can be validated by multiple assay platforms, such as ELISA, WB, IHC, FACS, et al., and can be tested by multi-tissue and multi-cell. All those verification aims to improve the screening success rate of low background and high sensitivity antibodies.
a)Multi-cell, multi-tissue validation
? Human stomach |
![]() |
Fig 1. Immunochemical staining of human target E with rabbit Mab. The image showing membrane staining of epithelium cell. |
? Human rectal cancer |
![]() |
Fig 2. Immunochemical staining of human target E with rabbit Mab. The image showing membrane staining of epithelium cell in intestinal gland. |
? Human placenta |
![]() |
Fig 3. Immunochemical staining of human target E with rabbit Mab. The image showing positive staining of trophoblast. |
? Human liver |
![]() |
Fig 4. Immunochemical staining of human target E with rabbit Mab. The image showing membrane staining of hepatocyte. |
? Human gastric cancer |
![]() |
Fig 5. Immunochemical staining of human target E with rabbit Mab. The image showing membrane staining of epithelium cell. |
? Human esophagus |
![]() |
Fig 6. Immunochemical staining of human target E with rabbit Mab. The image showing membrane staining of squamous epithelium cell. The left panel: tissue incubated with primary antibody; The right panel: tissue incubated with the mixture of primary antibody and antigen. |
b)Multi-application verification
![]() |
Fig 1. Immunofluorescence staining of target E in monkey stomach with rabbit Mab. The image showing membrane staining of gastric gland cell. The right panel: merge with DAPI. |
![]() |
Fig 2. Immunofluorescence staining of human target E in HeLa cells with rabbit Mab. The image showing membrane staining of HeLa cells. |
![]() |
Fig 3. Lane A: A431 Whole Cell Lysate. Anti-target E rabbit Mab; Goat Anti-Rabbit IgG H&L (Dylight800). |
![]() |
Fig 4. Lane A: K562 Whole Cell Lysate. Anti-target E rabbit Mab; Clean-Blot? IP Detection Reagent (HRP). |
![]() |
Fig 5. Analysis of anti-target E reactivity on HeLa cells. |
a)Multi-cell, multi-tissue validation
? Human mammary gland |
![]() |
Fig 1. Immunochemical staining of human target F with rabbit Mab. Positive staining was localized to membrane of alveolus epithelium. |
? Human colon carcinoma |
![]() |
Fig 2. Immunochemical staining of human target F with rabbit Mab. Positive staining was localized to membrane of colonic gland epithelium. |
? Human bladder carcinoma |
![]() |
Fig 3. Immunochemical staining of human target F with rabbit Mab. Positive staining was localized to membrane of transitional epithelium. |
b)Multi-application verification
![]() |
Fig 1. Immunofluorescence staining of human target F in SKBR3 cells. Positive staining was localized to plasma membrane. |
![]() |
Fig 2. Lane A: MCF-7 Whole Cell Lysate. Anti-target F rabbit Mab; Goat Anti-Rabbit IgG H&L (Dylight800). |
![]() |
Fig 3. Flow cytometric analysis of anti-target F reactivity on SKBR3 cells. The histogram were derived from the gated events based on light scattering characteristics of viable cells. |
![]() |
Fig 4. Lane A: MCF-7 Whole Cell Lysate; Lane B: A431 Whole Cell Lysate; Lane C: HepG2 Whole Cell Lysate; Lane D: Caco-2 Whole Cell Lysate. Anti-target F rabbit Mab; Dylight 800-labeled antibody to rabbit IgG (H+L). |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
Secondary generation techniques | Liquid and solid phase screening | Varied detection platforms can insure the high quality |
High affinity Recognize murine antibodies |
High specificity & low background Easy to be humanized |
Identify more novel epitopes Larger antibody libraries |
The second-generation rabbit mAb can be directly modified for genetic engineering |